These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 38251353)

  • 21. HBsAg-negative hepatitis B virus infection and hepatocellular carcinoma.
    Chen L; Zhao H; Yang X; Gao JY; Cheng J
    Discov Med; 2014 Oct; 18(99):189-93. PubMed ID: 25336032
    [TBL] [Abstract][Full Text] [Related]  

  • 22. State of the art treatment of hepatitis B virus hepatocellular carcinoma and the role of hepatitis B surface antigen post-liver transplantation and resection.
    Schemmer P; Burra P; Hu RH; Hüber CM; Loinaz C; Machida K; Vogel A; Samuel D
    Liver Int; 2022 Feb; 42(2):288-298. PubMed ID: 34846790
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hepatitis B virus large surface protein is priming for hepatocellular carcinoma development via induction of cytokinesis failure.
    Musa J; Li J; Grünewald TG
    J Pathol; 2019 Jan; 247(1):6-8. PubMed ID: 30246253
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High levels of hepatitis B surface antigen increase risk of hepatocellular carcinoma in patients with low HBV load.
    Tseng TC; Liu CJ; Yang HC; Su TH; Wang CC; Chen CL; Kuo SF; Liu CH; Chen PJ; Chen DS; Kao JH
    Gastroenterology; 2012 May; 142(5):1140-1149.e3; quiz e13-4. PubMed ID: 22333950
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hepatitis B Gene Therapy Coming to Age.
    Soriano V
    AIDS Rev; 2018; 20(2):125-127. PubMed ID: 29938706
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intrahepatic quantification of HBV antigens in chronic hepatitis B reveals heterogeneity and treatment-mediated reductions in HBV core-positive cells.
    Aggarwal A; Odorizzi PM; Brodbeck J; van Buuren N; Moon C; Chang S; Adona M; Suthram S; Suri V; Trowe T; Turner S; Marcellin P; Buti M; Gaggar A; Fletcher SP; Diehl L; Feierbach B; Balsitis S
    JHEP Rep; 2023 Apr; 5(4):100664. PubMed ID: 36908748
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of silent hepatitis B virus in chronic hepatitis B surface antigen(-) liver disease.
    Chemin I; Jeantet D; Kay A; Trépo C
    Antiviral Res; 2001 Nov; 52(2):117-23. PubMed ID: 11672821
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Quantification of large and middle proteins of hepatitis B virus surface antigen (HBsAg) as a novel tool for the identification of inactive HBV carriers.
    Pfefferkorn M; Böhm S; Schott T; Deichsel D; Bremer CM; Schröder K; Gerlich WH; Glebe D; Berg T; van Bömmel F
    Gut; 2018 Nov; 67(11):2045-2053. PubMed ID: 28951526
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hepatitis B-related outcomes following direct-acting antiviral therapy in Taiwanese patients with chronic HBV/HCV co-infection.
    Yeh ML; Huang CF; Huang CI; Holmes JA; Hsieh MH; Tsai YS; Liang PC; Tsai PC; Hsieh MY; Lin ZY; Chen SC; Huang JF; Dai CY; Chuang WL; Chung RT; Yu ML
    J Hepatol; 2020 Jul; 73(1):62-71. PubMed ID: 32061869
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Late HBsAg seroreversion of mutated hepatitis B virus after bone marrow transplantation.
    Schubert A; Michel D; Mertens T
    BMC Infect Dis; 2013 May; 13():223. PubMed ID: 23679074
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of hepatitis B virus genotype D & its mutants in occult hepatitis B infection.
    Sengupta S; Panda SK; Acharya SK; Durgapal H
    Indian J Med Res; 2013 Sep; 138(3):329-39. PubMed ID: 24135177
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hepatitis B surface antigen (HBsAg) levels in the natural history of hepatitis B virus (HBV)-infection: a European perspective.
    Jaroszewicz J; Calle Serrano B; Wursthorn K; Deterding K; Schlue J; Raupach R; Flisiak R; Bock CT; Manns MP; Wedemeyer H; Cornberg M
    J Hepatol; 2010 Apr; 52(4):514-22. PubMed ID: 20207438
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hepatitis B Virus-Encoded HBsAg Contributes to Hepatocarcinogenesis by Inducing the Oncogenic Long Noncoding RNA LINC00665 through the NF-κB Pathway.
    Ahluwalia S; Ahmad B; Salim U; Ghosh D; Kamuju V; Ghosh A; Dabeer K; Menon MB; Vivekanandan P
    Microbiol Spectr; 2022 Oct; 10(5):e0273121. PubMed ID: 35993712
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evolutionary Analysis of Pre-S/S Mutations in HBeAg-Negative Chronic Hepatitis B With HBsAg < 100 IU/ml.
    Wu Y; Zhu Z; Wu J; Bi W; Xu W; Xia X; Han D
    Front Public Health; 2021; 9():633792. PubMed ID: 33981663
    [No Abstract]   [Full Text] [Related]  

  • 35. Impact of HBsAg seroclearance on late recurrence of hepatitis B virus-related hepatocellular carcinoma after surgical resection.
    Yoo S; Kim JY; Lim YS; Han S; Choi J
    J Hepatol; 2022 Oct; 77(4):939-946. PubMed ID: 35643206
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical utility of HBV surface antigen quantification in HBV e antigen-negative chronic HBV infection.
    Liaw YF
    Nat Rev Gastroenterol Hepatol; 2019 Oct; 16(10):631-641. PubMed ID: 31477873
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-term follow-up of children with postnatal immunoprophylaxis failure who were infected with hepatitis B virus surface antigen gene mutant.
    Hsu HY; Chang MH; Ni YH; Jeng YM; Chiang CL; Chen HL; Wu JF; Chen PJ
    J Infect Dis; 2013 Apr; 207(7):1047-57. PubMed ID: 23300165
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reactivation of hepatitis B virus in HBsAg-negative patients with hepatocellular carcinoma.
    Jang JW; Kim YW; Lee SW; Kwon JH; Nam SW; Bae SH; Choi JY; Yoon SK; Chung KW
    PLoS One; 2015; 10(3):e0122041. PubMed ID: 25894607
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Management of Hepatitis B Virus in Allogeneic Hematopoietic Stem Cell Transplantation.
    Wu Y; Huang H; Luo Y
    Front Immunol; 2020; 11():610500. PubMed ID: 33613534
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hepatitis B virus core-related antigen (HBcrAg) as a prognostic marker for the development of hepatocellular carcinoma: A mini systematic review of the literature.
    Afifi AM; Elgenidy A; Hashim M; Awad AK; Jalal PK
    Rev Med Virol; 2022 Nov; 32(6):e2353. PubMed ID: 35441759
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.